Verona Pharma PLC

Common Name

Verona Pharma

Country

United Kingdom

Sector

Healthcare

Industry

Biotechnology

Employees

209

Ticker

VRNA

Exchange

NASDAQ/NMS

Website

www.veronapharma.com

Description

Verona Pharma plc is a clinical-stage biopharmaceutical company focusing on the development of therapeutics for respiratory conditions with unmet medical needs. The company's primary objective is to c... Show more

Financial Statements of Verona Pharma

Below are the financial statements of Verona Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	399.76^a	271.77^a
Accounts receivable, net	31.5^a	0^a
Prepaid expenses	7.57^a	3.62^a
Tax incentive receivable	5.76^a	10.95^a
Inventory	6.25^a	0^a
Other current assets	2.74^a	3.37^a
Total current assets	453.57^a	289.71^a
Non-current assets	—	—
Furniture and equipment, net	1.11^a	0.02^a
Inventory, long-term	1.97^a	0^a
Goodwill	0.55^a	0.55^a
Equity interest	15^a	15^a
Right-of-use assets	2.05^a	2.85^a
Total non-current assets	20.67^a	18.42^a
Total assets	474.24^a	308.12^a
Current liabilities	—	—
Accounts payable	11.27^a	3.49^a
Accrued expenses	16.76^a	3.59^a
Royalties payable	1.1^a	0^a
Revenue interest purchase and sale agreement	0.69^a	0^a
Current operating lease liabilities	1.12^a	1.18^a
Taxes payable	8.89^a	0^a
Other current liabilities	2.86^a	0.44^a
Total current liabilities	42.68^a	8.69^a
Non-current liabilities	—	—
Term loan	120.34^a	48.37^a
Revenue interest purchase and sale agreement	105.42^a	0^a
Non-current operating lease liabilities	1.24^a	1.78^a
Total non-current liabilities	227^a	50.15^a
Liabilities and shareholders' equity	—	—
Total liabilities	269.68^a	58.84^a
Commitments and contingencies	0^a	0^a
Shareholders' equity	—	—
Ordinary shares	45.02^a	42.77^a
Additional paid-in capital	728.2^a	601.06^a
Ordinary shares held in treasury	-1.66^a	-1.52^a
Accumulated other comprehensive loss	-4.6^a	-4.6^a
Accumulated deficit	-562.4^a	-388.43^a
Total shareholders' equity	204.56^a	249.28^a
Total liabilities and shareholders' equity	474.24^a	308.12^a

Verified Sources Behind Verona Pharma’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Verona Pharma’s data sources below and access millions more through our Disclosure Search.

a. Verona Pharma's 10-K 2024

Trace every data point back to Verona Pharma’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Verona Pharma PLC

Financial Statements of Verona Pharma

Verified Sources Behind Verona Pharma’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Roivant Sciences Ltd

LivaNova PLC

AstraZeneca PLC

GSK plc

Smith & Nephew PLC

Haleon PLC